'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak

Nature Communications

Volumn 5, Issue , 2014, Pages

  Voelz, Kerstin ^a,b   Johnston, Simon A ^c,d   Smith, Leanne M ^a   Hall, Rebecca A ^a   Idnurm, Alexander ^e   May, Robin C ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; GREEN FLUORESCENT PROTEIN; HOG1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE;

FUNGAL DISEASE; GENE EXPRESSION; IMMUNE RESPONSE; MITOCHONDRION; OXYGEN; PATHOGEN; POPULATION OUTBREAK; YEAST;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CRYPTOCOCCUS GATTII; FUNGAL CELL; FUNGUS GROWTH; GENE EXPRESSION PROFILING; HOST; INNATE IMMUNITY; MACROPHAGE; MITOCHONDRIAL GENE; MITOCHONDRION; MIXED INFECTION; MYCOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POPULATION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; ANIMAL; AUTOPHAGY; CELL LINE; CRYPTOCOCCOSIS; DISEASE MODEL; EPIDEMIC; GENOTYPE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY;

CRYPTOCOCCUS GATTII;

ANIMALS; AUTOPHAGY; CELL LINE; CELL PROLIFERATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; GENOTYPE; GREEN FLUORESCENT PROTEINS; IMMUNITY, INNATE; MACROPHAGES; MICE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

EID: 84911405863     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6194     Document Type: Article

References (57)

1. Brown, G. D., Denning, D. W. & Levitz, S. M. Tackling human fungal infections. Science 336, 647 (2012).
2. Fisher, M. C. et al. Emerging fungal threats to animal, plant and ecosystem health. Nature 484, 186-194 (2012).
3. Park, B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530 (2009).
4. Chen, J. et al. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg. Infect. Dis. 14, 755-762 (2008).
5. Lui, G. et al. Cryptococcosis in apparently immunocompetent patients. QJM 99, 143-151 (2006).
6. Idnurm, A. et al. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat. Rev. Microbiol. 3, 753-764 (2005).
7. Kronstad, J. W. et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 9, 193-203 (2011).
8. Byrnes, 3rd E. J. et al. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog. 7, e1002205 (2011).
9. Litvintseva, A. P., Thakur, R., Reller, L. B. & Mitchell, T. G. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J. Infect. Dis. 192, 888-892 (2005).
10. Bartlett, K. H., Kidd, S. E. & Kronstad, J. W. The Emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr. Infect. Dis. Rep. 10, 58-65 (2008).
11. Kidd, S. E. et al. Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg. Infect. Dis. 13, 51-57 (2007).
12. Kidd, S. E. et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl Acad. Sci. USA 101, 17258-17263 (2004).
13. Byrnes, E. J. & Heitman, J. Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences. F1000 Biol. Rep. 1, 62 (2009).
14. Byrnes, 3rd E. J. et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 6, e1000850 (2010).
15. Byrnes, 3rd E. J. et al. First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLoS ONE 4, e5851 (2009).
16. Datta, K. et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg. Infect. Dis. 15, 1185-1191 (2009).
17. Byrnes, 3rd E. J., Bartlett, K. H., Perfect, J. R. & Heitman, J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect. 13, 895-907 (2011).
18. Galanis, E., Macdougall, L., Kidd, S. & Morshed, M. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg. Infect. Dis. 16, 251-257 (2010).
19. Patrick, S. et al. Emergence of Cryptococcus gattii-Pacific Northwest, 2004-2010. Morb. Mortal. Wkly Rep. 59, 865-868 (2010).
20. Marr, K. A. Cryptococcus gattii as an important fungal pathogen of western North America. Expert. Rev. Anti Infect. Ther. 10, 637-643 (2012).
21. Kidd, S. E., Guo, H., Bartlett, K. H., Xu, J. & Kronstad, J. W. Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot. Cell 4, 1629-1638 (2005).
22. Byrnes, 3rd E. J. et al. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J. Infect. Dis. 199, 1081-1086 (2009).
23. Fraser, J. A. et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437, 1360-1364 (2005).
24. Hagen, F. et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS ONE 8, e71148 (2013).
25. Ma, H. et al. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc. Natl Acad. Sci. USA 106, 12980-12985 (2009).
26. Voelz, K. et al. Transmission of hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen Cryptococcus gattii. PLoS Genet. 9, e1003771 (2013).
27. Gomes, L. C., Di Benedetto, G. & Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13, 589-598 (2011).
28. Scheckhuber, C. Q. et al. Reducing mitochondrial fission results in increased life span and fitness of two fungal ageing models. Nat. Cell Biol. 9, 99-105 (2007).
29. Rambold, A. S., Kostelecky, B., Elia, N. & Lippincott-Schwartz, J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc. Natl Acad. Sci. USA 108, 10190-10195 (2011).
30. West, S. A., Griffin, A. S., Gardner, A. & Diggle, S. P. Social evolution theory for microorganisms. Nat. Rev. Microbiol. 4, 597-607 (2006).
31. Bigger, J. W. Treatment pf staphylococcal infections with penecillin by intermittent sterilisation. Lancet 244, 497-500 (1944).
32. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622-1625 (2004).
33. VanderVen, B. C., Yates, R. M. & Russell, D. G. Intraphagosomal measurement of the magnitude and duration of the oxidative burst. Traffic 10, 372-378 (2009).
34. Alonso-Monge, R. et al. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J. Bacteriol. 181, 3058-3068 (1999).
35. Bahn, Y. S., Kojima, K., Cox, G. M. & Heitman, J. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol. Biol. Cell 16, 2285-2300 (2005).
36. Olson, A. & Stenlid, J. Plant pathogens. Mitochondrial control of fungal hybrid virulence. Nature 411, 438 (2001).
37. Barelle, C. J. et al. Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell. Microbiol. 8, 961-971 (2006).
38. Becker, J. M. et al. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proc. Natl Acad. Sci. USA 107, 22044-22049 (2010).
39. Brun, S. et al. Biological consequences of petite mutations in Candida glabrata. J. Antimicrob. Chemother. 56, 307-314 (2005).
40. Magnani, T. et al. Silencing of mitochondrial alternative oxidase gene of Aspergillus fumigatus enhances reactive oxygen species production and killing of the fungus by macrophages. J. Bioenerg. Biomembr. 40, 631-636 (2008).
41. Narasipura, S. D., Chaturvedi, V. & Chaturvedi, S. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence. Mol. Microbiol. 55, 1782-1800 (2005).
42. Noble, S. M., French, S., Kohn, L. A., Chen, V. & Johnson, A. D. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42, 590-598 (2010).
43. Price, M. S. et al. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. MBio 2, e00103-e00111 (2011).
44. Steen, B. R. et al. Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryot. Cell 2, 1336-1349 (2003).
45. Bambach, A. et al. Goa1p of Candida albicans localizes to the mitochondria during stress and is required for mitochondrial function and virulence. Eukaryot. Cell 8, 1706-1720 (2009).
46. Martins, V. P. et al. Involvement of an alternative oxidase in oxidative stress and mycelium-to-yeast differentiation in Paracoccidioides brasiliensis. Eukaryot. Cell 10, 237-248 (2011).
47. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48-56 (2006).
48. Arnoldini, M. et al. Bistable expression of virulence genes in salmonella leads to the formation of an antibiotic-tolerant subpopulation. PLoS Biol. 12, e1001928 (2014).
49. Lin, X. & Heitman, J. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60, 69-105 (2006).
50. Bicanic, T., Harrison, T., Niepieklo, A., Dyakopu, N. & Meintjes, G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin. Infect. Dis. 43, 1069-1073 (2006).
51. Voelz, K., Johnston, S. A., Rutherford, J. C. & May, R. C. Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS ONE 5, e15968 (2010).
52. Ralph, P., Prichard, J. & Cohn, M. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J. Immunol. 114, 898-905 (1975).
53. Voelz, K., Lammas, D. A. & May, R. C. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect. Immun. 77, 3450-3457 (2009).
54. Ma, H., Croudace, J. E., Lammas, D. A. & May, R. C. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16, 2156-2160 (2006).
55. Idnurm, A. & Heitman, J. Ferrochelatase is a conserved downstream target of the blue light-sensing White collar complex in fungi. Microbiology 156, 2393-2407 (2010).
56. Bundock, P., den Dulk-Ras, A., Beijersbergen, A. & Hooykaas, P. J. Transkingdom T-DNA transfer from Agrobacterium tumefaciens to Saccharomyces cerevisiae. EMBO J. 14, 3206-3214 (1995).
57. Ma, H. Intracellular parasitism of macrophages by Cryptococcus. Doctor of Philosophy thesis, Univ. Birmingham http://www.biosciences-labs.bham.ac.uk/may/Publications-files/Hansong%20Ma's%20Thesis%20Final.pdf (2009).